_id
69147ab2ccc777a4e85d9000
Ticker
MNPR
Name
Monopar Therapeutics Inc
Exchange
NASDAQ
Address
1000 Skokie Boulevard, Wilmette, IL, United States, 60091
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.monopartx.com
Description
Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. The company develops ALXN1840, a late-stage, investigational once-daily and oral medicine; MNPR-101, a proprietary humanized monoclonal antibody that is conjugated with different radioisotopes for the treatment of advanced solid tumors expressing urokinase plasminogen activator receptor; and MNPR-101-Zr, a clinical-stage radiodiagnostic imaging agent comprised of MNPR-101 conjugated to zirconium-89. It develops MNPR-101-Lu, a late-preclinical stage radiotherapeutic comprised of MNPR-101 conjugated to actinium-225. The company has collaborations NorthStar to develop radio-immuno-therapeutics targeting severe COVID-19. The company was founded in 2014 and is headquartered in Wilmette, Illinois.
Last Close
78.22
Volume
100682
Current Price
75.47
Change
-3.515724878547686
Last Updated
2025-12-02T12:00:17.509Z
Image
data:image/webp;base64,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
Ipo Date
2019-12-19T00:00:00.000Z
Market Cap
555055424
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.681
Sentiment Sources
3
Rating
4.2
Target Price
111.7692
Strong Buy
2
Buy
2
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
4093075
Operating Income
-4093075
Interest Expense
-
Pretax Income
-3437601
Net Income
-3437601
Eps
-0.48254826849923405
Dividends Per Share
-
Shares Outstanding
6682584
Income Tax Expense
-
EBITDA
-3437601
Operating Margin
-
Total Other Income Expense Net
655474
Cash
127677000
Short Term Investments
15998427
Receivables
-
Inventories
-
Total Current Assets
144090000
Property Plant Equipment
106666
Total Assets
144197000
Payables
2537194
Short Term Debt
31355
Long Term Debt
-
Total Liabilities
2640000
Equity
141557000
Depreciation
-
Change In Working Capital
247859
Cash From Operations
-2090532
Capital Expenditures
2
Cash From Investing
-2126027
Cash From Financing
92391609
Net Change In Cash
88175424
PE
-
PB
3.798024004676561
ROE
-2.4284217664968883
ROA
-2.3839615248583534
FCF
-2090534
Fcf Percent
-
Piotroski FScore
1
Health Score
38
Deep Value Investing Score
3.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
4093075
Quarters > 0 > income Statement > operating Income
-4093075
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-3437601
Quarters > 0 > income Statement > net Income
-3437601
Quarters > 0 > income Statement > eps
-0.48254826849923405
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
7123849
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-3437601
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
655474
Quarters > 0 > balance Sheet > cash
127677000
Quarters > 0 > balance Sheet > short Term Investments
15998427
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
144090000
Quarters > 0 > balance Sheet > property Plant Equipment
106666
Quarters > 0 > balance Sheet > total Assets
144197000
Quarters > 0 > balance Sheet > payables
2537194
Quarters > 0 > balance Sheet > short Term Debt
31355
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
2640000
Quarters > 0 > balance Sheet > equity
141557000
Quarters > 0 > cash Flow > net Income
-3437601
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
247859
Quarters > 0 > cash Flow > cash From Operations
-2090532
Quarters > 0 > cash Flow > capital Expenditures
2
Quarters > 0 > cash Flow > cash From Investing
-2126027
Quarters > 0 > cash Flow > cash From Financing
92391609
Quarters > 0 > cash Flow > net Change In Cash
88175424
Quarters > 0 > ratios > PE
-0.48254826849923405
Quarters > 0 > ratios > PB
3.798024004676561
Quarters > 0 > ratios > ROE
-2.4284217664968883
Quarters > 0 > ratios > ROA
-2.3839615248583534
Quarters > 0 > ratios > FCF
-2090534
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
38
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
3234295
Quarters > 1 > income Statement > operating Income
-3234295
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-2453526
Quarters > 1 > income Statement > net Income
-2453526
Quarters > 1 > income Statement > eps
-0.35059977862505753
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
6998082
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-2453526
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
780769
Quarters > 1 > balance Sheet > cash
39501936
Quarters > 1 > balance Sheet > short Term Investments
13748473
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
53747703
Quarters > 1 > balance Sheet > property Plant Equipment
118170
Quarters > 1 > balance Sheet > total Assets
53865873
Quarters > 1 > balance Sheet > payables
1583613
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
1663979
Quarters > 1 > balance Sheet > equity
52201894
Quarters > 1 > cash Flow > net Income
-2453526
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
96609
Quarters > 1 > cash Flow > cash From Operations
-1077371
Quarters > 1 > cash Flow > capital Expenditures
1
Quarters > 1 > cash Flow > cash From Investing
1187294
Quarters > 1 > cash Flow > cash From Financing
-316845
Quarters > 1 > cash Flow > net Change In Cash
-209473
Quarters > 1 > ratios > PE
-0.35059977862505753
Quarters > 1 > ratios > PB
10.117357974406064
Quarters > 1 > ratios > ROE
-4.700070844172818
Quarters > 1 > ratios > ROA
-4.55488023001131
Quarters > 1 > ratios > FCF
-1077372
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
35
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
3221817
Quarters > 2 > income Statement > operating Income
-3221817
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-2624972
Quarters > 2 > income Statement > net Income
-2624972
Quarters > 2 > income Statement > eps
-0.3756937169028195
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
6987000
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-3221817
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
596845
Quarters > 2 > balance Sheet > cash
39711409
Quarters > 2 > balance Sheet > short Term Investments
14841251
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
55076216
Quarters > 2 > balance Sheet > property Plant Equipment
9102
Quarters > 2 > balance Sheet > total Assets
55085318
Quarters > 2 > balance Sheet > payables
1491960
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
1491960
Quarters > 2 > balance Sheet > equity
53593358
Quarters > 2 > cash Flow > net Income
-2624972
Quarters > 2 > cash Flow > depreciation
3222000
Quarters > 2 > cash Flow > change In Working Capital
-4393361
Quarters > 2 > cash Flow > cash From Operations
-5663316
Quarters > 2 > cash Flow > capital Expenditures
4
Quarters > 2 > cash Flow > cash From Investing
-325828
Quarters > 2 > cash Flow > cash From Financing
-115682
Quarters > 2 > cash Flow > net Change In Cash
-6104880
Quarters > 2 > ratios > PE
-0.3756937169028195
Quarters > 2 > ratios > PB
9.839071662574307
Quarters > 2 > ratios > ROE
-4.897942763728296
Quarters > 2 > ratios > ROA
-4.7652842813760286
Quarters > 2 > ratios > FCF
-5663320
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
11074644
Quarters > 3 > income Statement > operating Income
-11074644
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-10925608
Quarters > 3 > income Statement > net Income
-10925608
Quarters > 3 > income Statement > eps
-0.9514179474898767
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
11483500
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-10925608
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
149036
Quarters > 3 > balance Sheet > cash
45816289
Quarters > 3 > balance Sheet > short Term Investments
14395913
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
60291071
Quarters > 3 > balance Sheet > property Plant Equipment
0
Quarters > 3 > balance Sheet > total Assets
60291071
Quarters > 3 > balance Sheet > payables
2254300
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
5254300
Quarters > 3 > balance Sheet > equity
55036771
Quarters > 3 > cash Flow > net Income
-10925608
Quarters > 3 > cash Flow > depreciation
11075000
Quarters > 3 > cash Flow > change In Working Capital
4096320
Quarters > 3 > cash Flow > cash From Operations
-1998418
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-14338403
Quarters > 3 > cash Flow > cash From Financing
56136829
Quarters > 3 > cash Flow > net Change In Cash
39796205
Quarters > 3 > ratios > PE
-0.9514179474898767
Quarters > 3 > ratios > PB
15.746922089597154
Quarters > 3 > ratios > ROE
-19.851469847313535
Quarters > 3 > ratios > ROA
-18.121436257120063
Quarters > 3 > ratios > FCF
-1998418
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
35
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
16161721
Annuals > 0 > income Statement > operating Income
-16161721
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-15586419
Annuals > 0 > income Statement > net Income
-15586419
Annuals > 0 > income Statement > eps
-1.3572881961074585
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
11483500
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-16161721
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
575302
Annuals > 0 > balance Sheet > cash
45816289
Annuals > 0 > balance Sheet > short Term Investments
14395913
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
60291071
Annuals > 0 > balance Sheet > property Plant Equipment
0
Annuals > 0 > balance Sheet > total Assets
60291071
Annuals > 0 > balance Sheet > payables
2254300
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
5254300
Annuals > 0 > balance Sheet > equity
55036771
Annuals > 0 > cash Flow > net Income
-15586419
Annuals > 0 > cash Flow > depreciation
16162000
Annuals > 0 > cash Flow > change In Working Capital
3489237
Annuals > 0 > cash Flow > cash From Operations
-6404139
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-14338403
Annuals > 0 > cash Flow > cash From Financing
59292257
Annuals > 0 > cash Flow > net Change In Cash
38550209
Annuals > 0 > ratios > PE
-1.3572881961074585
Annuals > 0 > ratios > PB
17.33058630928766
Annuals > 0 > ratios > ROE
-28.320009907557985
Annuals > 0 > ratios > ROA
-25.85195243919286
Annuals > 0 > ratios > FCF
-6404139
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
27
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
8831235
Annuals > 1 > income Statement > operating Income
-8831235
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-8402196
Annuals > 1 > income Statement > net Income
-8402196
Annuals > 1 > income Statement > eps
-0.5790225346289022
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
14511000
Annuals > 1 > income Statement > income Tax Expense
-8831.23
Annuals > 1 > income Statement > EBITDA
-8831235
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
429039
Annuals > 1 > balance Sheet > cash
7266080
Annuals > 1 > balance Sheet > short Term Investments
0
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
7332513
Annuals > 1 > balance Sheet > property Plant Equipment
12646
Annuals > 1 > balance Sheet > total Assets
7345159
Annuals > 1 > balance Sheet > payables
1757393
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
1757393
Annuals > 1 > balance Sheet > equity
5587766
Annuals > 1 > cash Flow > net Income
-8402196
Annuals > 1 > cash Flow > depreciation
8831000
Annuals > 1 > cash Flow > change In Working Capital
-1353946
Annuals > 1 > cash Flow > cash From Operations
-7858293
Annuals > 1 > cash Flow > capital Expenditures
3
Annuals > 1 > cash Flow > cash From Investing
4927748
Annuals > 1 > cash Flow > cash From Financing
2027227
Annuals > 1 > cash Flow > net Change In Cash
-920114
Annuals > 1 > ratios > PE
-0.5790225346289022
Annuals > 1 > ratios > PB
215.70045345492275
Annuals > 1 > ratios > ROE
-150.3677140381326
Annuals > 1 > ratios > ROA
-114.39093421939539
Annuals > 1 > ratios > FCF
-7858296
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
26
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
10536877
Annuals > 2 > income Statement > operating Income
-10536877
Annuals > 2 > income Statement > interest Expense
21239
Annuals > 2 > income Statement > pretax Income
-10515638
Annuals > 2 > income Statement > net Income
-10494399
Annuals > 2 > income Statement > eps
-0.8251611102374588
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
12718000
Annuals > 2 > income Statement > income Tax Expense
-21239
Annuals > 2 > income Statement > EBITDA
-10515638
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
21239
Annuals > 2 > balance Sheet > cash
8186194
Annuals > 2 > balance Sheet > short Term Investments
4933550
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
13165726
Annuals > 2 > balance Sheet > property Plant Equipment
61228
Annuals > 2 > balance Sheet > total Assets
13226954
Annuals > 2 > balance Sheet > payables
3128894
Annuals > 2 > balance Sheet > short Term Debt
48582
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
3137302
Annuals > 2 > balance Sheet > equity
10089652
Annuals > 2 > cash Flow > net Income
-10515638
Annuals > 2 > cash Flow > depreciation
21239
Annuals > 2 > cash Flow > change In Working Capital
1645816
Annuals > 2 > cash Flow > cash From Operations
-7228559
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-4918511
Annuals > 2 > cash Flow > cash From Financing
32873
Annuals > 2 > cash Flow > net Change In Cash
-12117675
Annuals > 2 > ratios > PE
-0.8251611102374588
Annuals > 2 > ratios > PB
104.6970777584797
Annuals > 2 > ratios > ROE
-104.01150604599643
Annuals > 2 > ratios > ROA
-79.34101078751767
Annuals > 2 > ratios > FCF
-7228559
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
27
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
9127248
Annuals > 3 > income Statement > operating Income
-9127248
Annuals > 3 > income Statement > interest Expense
24024
Annuals > 3 > income Statement > pretax Income
-9103224
Annuals > 3 > income Statement > net Income
-9079200
Annuals > 3 > income Statement > eps
-0.7279666452854394
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
12472000
Annuals > 3 > income Statement > income Tax Expense
-24024
Annuals > 3 > income Statement > EBITDA
-9079200
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
24024
Annuals > 3 > balance Sheet > cash
20303869
Annuals > 3 > balance Sheet > short Term Investments
0
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
20521614
Annuals > 3 > balance Sheet > property Plant Equipment
0
Annuals > 3 > balance Sheet > total Assets
20521614
Annuals > 3 > balance Sheet > payables
1580543
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
1580543
Annuals > 3 > balance Sheet > equity
18941071
Annuals > 3 > cash Flow > net Income
-9103224
Annuals > 3 > cash Flow > depreciation
48048
Annuals > 3 > cash Flow > change In Working Capital
317769
Annuals > 3 > cash Flow > cash From Operations
-7317401
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
10879537
Annuals > 3 > cash Flow > net Change In Cash
3566760
Annuals > 3 > ratios > PE
-0.7279666452854394
Annuals > 3 > ratios > PB
54.69196118846711
Annuals > 3 > ratios > ROE
-47.933931507885696
Annuals > 3 > ratios > ROA
-44.242134171318106
Annuals > 3 > ratios > FCF
-7317401
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
26
Valuation > metrics > PE
-0.48254826849923405
Valuation > metrics > PB
3.798024004676561
Valuation > final Score
42.019759953234384
Valuation > verdict
26.6% Overvalued
Profitability > metrics > ROE
-2.4284217664968883
Profitability > metrics > ROA
-2.385731834270248
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.018649731203684735
Risk > final Score
80
Risk > verdict
Low
Liquidity > metrics > Current Ratio
56.097820208997376
Liquidity > metrics > Quick Ratio
56.097820208997376
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
80
Prev Risks > 1
38
Prev Risks > 2
80
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-12T00:45:02.164Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-10
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.48
Earnings History > 0 > eps Estimate
-0.3989
Earnings History > 0 > eps Difference
-0.0811
Earnings History > 0 > surprise Percent
-20.3309
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-12
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.35
Earnings History > 1 > eps Estimate
-0.09
Earnings History > 1 > eps Difference
-0.26
Earnings History > 1 > surprise Percent
-288.8889
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-07
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.38
Earnings History > 2 > eps Estimate
-0.5667
Earnings History > 2 > eps Difference
0.1867
Earnings History > 2 > surprise Percent
32.9451
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-26
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-2.75
Earnings History > 3 > eps Estimate
-0.42
Earnings History > 3 > eps Difference
-2.33
Earnings History > 3 > surprise Percent
-554.7619
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-07
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.37
Earnings History > 4 > eps Estimate
-0.48
Earnings History > 4 > eps Difference
0.11
Earnings History > 4 > surprise Percent
22.9167
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-09
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.5
Earnings History > 5 > eps Estimate
-0.47
Earnings History > 5 > eps Difference
-0.03
Earnings History > 5 > surprise Percent
-6.383
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-09
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.1
Earnings History > 6 > eps Estimate
-0.12
Earnings History > 6 > eps Difference
0.02
Earnings History > 6 > surprise Percent
16.6667
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-28
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.12
Earnings History > 7 > eps Estimate
-0.15
Earnings History > 7 > eps Difference
0.03
Earnings History > 7 > surprise Percent
20
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-09
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.14
Earnings History > 8 > eps Estimate
-0.17
Earnings History > 8 > eps Difference
0.03
Earnings History > 8 > surprise Percent
17.6471
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-10
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.16
Earnings History > 9 > eps Estimate
-0.18
Earnings History > 9 > eps Difference
0.02
Earnings History > 9 > surprise Percent
11.1111
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-11
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.19
Earnings History > 10 > eps Estimate
-0.22
Earnings History > 10 > eps Difference
0.03
Earnings History > 10 > surprise Percent
13.6364
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-23
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.23
Earnings History > 11 > eps Estimate
-0.2
Earnings History > 11 > eps Difference
-0.03
Earnings History > 11 > surprise Percent
-15
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-10
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.19
Earnings History > 12 > eps Estimate
-0.22
Earnings History > 12 > eps Difference
0.03
Earnings History > 12 > surprise Percent
13.6364
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-11
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.22
Earnings History > 13 > eps Estimate
-0.21
Earnings History > 13 > eps Difference
-0.01
Earnings History > 13 > surprise Percent
-4.7619
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-12
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.19
Earnings History > 14 > eps Estimate
-0.22
Earnings History > 14 > eps Difference
0.03
Earnings History > 14 > surprise Percent
13.6364
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-24
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.21
Earnings History > 15 > eps Estimate
-0.19
Earnings History > 15 > eps Difference
-0.02
Earnings History > 15 > surprise Percent
-10.5263
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-12
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.2
Earnings History > 16 > eps Estimate
-0.21
Earnings History > 16 > eps Difference
0.01
Earnings History > 16 > surprise Percent
4.7619
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-12
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.17
Earnings History > 17 > eps Estimate
-0.19
Earnings History > 17 > eps Difference
0.02
Earnings History > 17 > surprise Percent
10.5263
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-13
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.16
Earnings History > 18 > eps Estimate
-0.19
Earnings History > 18 > eps Difference
0.03
Earnings History > 18 > surprise Percent
15.7895
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-25
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.2
Earnings History > 19 > eps Estimate
-0.19
Earnings History > 19 > eps Difference
-0.01
Earnings History > 19 > surprise Percent
-5.2632
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-12
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.15
Earnings History > 20 > eps Estimate
-0.15
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
0
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-08-06
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.14
Earnings History > 21 > eps Estimate
-0.09
Earnings History > 21 > eps Difference
-0.05
Earnings History > 21 > surprise Percent
-55.5556
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-05-07
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
BeforeMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.1
Earnings History > 22 > eps Estimate
-0.11
Earnings History > 22 > eps Difference
0.01
Earnings History > 22 > surprise Percent
9.0909
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-03-27
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
BeforeMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.13
Earnings History > 23 > eps Estimate
-0.07
Earnings History > 23 > eps Difference
-0.06
Earnings History > 23 > surprise Percent
-85.7143
Earnings History > 24 > period
2019-09-30
Earnings History > 24 > report Date
2019-12-23
Earnings History > 24 > date
2019-09-30
Earnings History > 24 > before After Market
AfterMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.08
Earnings History > 24 > eps Estimate
0
Earnings History > 24 > eps Difference
-0.08
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2019-06-30
Earnings History > 25 > report Date
2019-08-08
Earnings History > 25 > date
2019-06-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.07
Earnings History > 25 > eps Estimate
0
Earnings History > 25 > eps Difference
-0.07
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2019-03-31
Earnings History > 26 > report Date
2019-05-10
Earnings History > 26 > date
2019-03-31
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.1
Earnings History > 26 > eps Estimate
0
Earnings History > 26 > eps Difference
-0.1
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2018-12-31
Earnings History > 27 > report Date
2019-02-26
Earnings History > 27 > date
2018-12-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-0.06
Earnings History > 27 > eps Estimate
0
Earnings History > 27 > eps Difference
-0.06
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2018-09-30
Earnings History > 28 > report Date
2018-11-09
Earnings History > 28 > date
2018-09-30
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-0.05
Earnings History > 28 > eps Estimate
0
Earnings History > 28 > eps Difference
-0.05
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2018-06-30
Earnings History > 29 > report Date
2018-08-09
Earnings History > 29 > date
2018-06-30
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-0.06
Earnings History > 29 > eps Estimate
0
Earnings History > 29 > eps Difference
-0.06
Earnings History > 29 > surprise Percent
-
Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. The company develops ALXN1840, a late-stage, investigational once-daily and oral medicine; MNPR-101, a proprietary humanized monoclonal antibody that is conjugated with different radioisotopes for the treatment of advanced solid tumors expressing urokinase plasminogen activator receptor; and MNPR-101-Zr, a clinical-stage radiodiagnostic imaging agent comprised of MNPR-101 conjugated to zirconium-89. It develops MNPR-101-Lu, a late-preclinical stage radiotherapeutic comprised of MNPR-101 conjugated to actinium-225. The company has collaborations NorthStar to develop radio-immuno-therapeutics targeting severe COVID-19. The company was founded in 2014 and is headquartered in Wilmette, Illinois.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AEKI Energy Services Limited Approaches Support With Recovery in Sight - Earnings Miss Alerts & Small Investment Wealth Growth earlytimes.in
Read more →How (MNPR) Movements Inform Risk Allocation Models news.stocktradersdaily.com
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$111.7692
Analyst Picks
Strong Buy
2
Buy
2
Hold
1
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 56.89% of the total shares of Monopar Therapeutics Inc
1.
HHG PLC(19.0012%)
since
2025/06/30
2.
Adage Capital Partners Gp LLC(9.7115%)
since
2025/06/30
3.
RA Capital Management, LLC(8.2854%)
since
2025/06/30
4.
BlackRock Inc(3.3253%)
since
2025/06/30
5.
Point72 Asset Management, L.P.(1.6859%)
since
2025/06/30
6.
ADAR1 Capital Management LLC(1.6365%)
since
2025/06/30
7.
Geode Capital Management, LLC(1.5708%)
since
2025/06/30
8.
iShares Russell 2000 ETF(1.5707%)
since
2025/08/31
9.
Vanguard Group Inc(1.4018%)
since
2025/06/30
10.
Affinity Asset Advisors, LLC(1.094%)
since
2025/06/30
11.
Vanguard Institutional Extnd Mkt Idx Tr(0.7395%)
since
2025/07/31
12.
State Street Corp(0.6779%)
since
2025/06/30
13.
Fidelity Small Cap Index(0.662%)
since
2025/06/30
14.
iShares Russell 2000 Growth ETF(0.6052%)
since
2025/08/31
15.
Ally Bridge Group (NY) LLC(0.5598%)
since
2025/06/30
16.
Northern Trust Corp(0.5156%)
since
2025/06/30
17.
Fidelity Extended Market Index(0.3751%)
since
2025/07/31
18.
UBS Group AG(0.3545%)
since
2025/06/30
19.
Vanguard Russell 2000 ETF(0.3139%)
since
2025/07/31
20.
Millennium Management LLC(0.2397%)
since
2025/06/30
21.
State St Russell Sm Cap® Indx SL Cl I(0.2318%)
since
2025/08/31
22.
Charles Schwab Investment Management Inc(0.2147%)
since
2025/06/30
23.
Schwab Small Cap Index(0.1661%)
since
2025/07/31
24.
NT R2000 Index Fund - NL(0.1594%)
since
2025/06/30
25.
iShares Micro-Cap ETF(0.1494%)
since
2025/08/31
26.
Bank of New York Mellon Corp(0.145%)
since
2025/06/30
27.
Susquehanna International Group, LLP(0.1354%)
since
2025/06/30
28.
Fidelity Total Market Index(0.1293%)
since
2025/07/31
29.
Morgan Stanley - Brokerage Accounts(0.1286%)
since
2025/06/30
30.
NT R2000 Index Fund - DC - NL - 3(0.1271%)
since
2025/06/30
31.
Barclays PLC(0.1181%)
since
2025/06/30
32.
iShares Russell 2000 Small-Cap Idx Instl(0.1141%)
since
2025/07/31
33.
Extended Equity Market Fund K(0.111%)
since
2025/06/30
34.
Russell 2500â„¢ Index Fund F(0.104%)
since
2025/06/30
35.
Citadel Advisors Llc(0.101%)
since
2025/06/30
36.
Fidelity Series Total Market Index(0.0982%)
since
2025/07/31
37.
Nuveen Small Cap Blend Idx R6(0.0855%)
since
2025/07/31
38.
Spartan Extended Market Index Pool F(0.0855%)
since
2025/07/31
39.
NT Ext Equity Mkt Idx Fd - L(0.0817%)
since
2025/06/30
40.
Northern Trust Extended Eq Market Idx(0.0817%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.48
EPS Estimate
-0.3989
EPS Difference
-0.0811
Surprise Percent
-20.3309%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.